Literature DB >> 25260797

Role of cortical spreading depression in the pathophysiology of migraine.

Yilong Cui1, Yosky Kataoka, Yasuyoshi Watanabe.   

Abstract

A migraine is a recurring neurological disorder characterized by unilateral, intense, and pulsatile headaches. In one-third of migraine patients, the attacks are preceded by a visual aura, such as a slowly-propagating scintillating scotoma. Migraine aura is thought to be a result of the neurovascular phenomenon of cortical spreading depression (SD), a self-propagating wave of depolarization that spreads across the cerebral cortex. Several animal experiments have demonstrated that cortical SD causes intracranial neurogenic inflammation around the meningeal blood vessels, such as plasma protein extravasation and pro-inflammatory peptide release. Cortical SD has also been reported to activate both peripheral and central trigeminal nociceptive pathways. Although several issues remain to be resolved, recent evidence suggests that cortical SD could be the initial trigger of intracranial neurogenic inflammation, which then contributes to migraine headaches via subsequent activation of trigeminal afferents.

Entities:  

Mesh:

Year:  2014        PMID: 25260797      PMCID: PMC5562594          DOI: 10.1007/s12264-014-1471-y

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  76 in total

1.  Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura.

Authors:  Marsha Smith; Didier Cros; Volney Sheen
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

2.  Distribution and functional properties of 5-HT3 receptors in the rat hippocampal dentate gyrus: a patch-clamp study.

Authors:  K Kawa
Journal:  J Neurophysiol       Date:  1994-05       Impact factor: 2.714

3.  Segregation of serotonin 5-HT2A and 5-HT3 receptors in inhibitory circuits of the primate cerebral cortex.

Authors:  R L Jakab; P S Goldman-Rakic
Journal:  J Comp Neurol       Date:  2000-02-14       Impact factor: 3.215

4.  Spreading depression is not associated with neuronal injury in the normal brain.

Authors:  M Nedergaard; A J Hansen
Journal:  Brain Res       Date:  1988-05-24       Impact factor: 3.252

5.  Migraine with aura shows gadolinium enhancement which is reversed following prophylactic treatment.

Authors:  G Arnold; U Reuter; S Kinze; T Wolf; K M Einhäupl
Journal:  Cephalalgia       Date:  1998-11       Impact factor: 6.292

6.  Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine.

Authors:  J Olesen; B Larsen; M Lauritzen
Journal:  Ann Neurol       Date:  1981-04       Impact factor: 10.422

7.  Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system.

Authors:  P J Goadsby; L Edvinsson; R Ekman
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

8.  Properties of feline thalamic neurons activated by stimulation of the middle meningeal artery and sagittal sinus.

Authors:  K D Davis; J O Dostrovsky
Journal:  Brain Res       Date:  1988-06-28       Impact factor: 3.252

9.  Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain.

Authors:  S Markowitz; K Saito; M A Moskowitz
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

Review 10.  Visualising microglial activation in vivo.

Authors:  Richard B Banati
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

View more
  12 in total

1.  Source localization of intermittent rhythmic delta activity in a patient with acute confusional migraine: cross-spectral analysis using standardized low-resolution brain electromagnetic tomography (sLORETA).

Authors:  Dae-Eun Kim; Jung-Hyun Shin; Young-Hoon Kim; Tae-Hoon Eom; Sung-Hun Kim; Jung-Min Kim
Journal:  Neurol Sci       Date:  2015-08-21       Impact factor: 3.307

2.  Neuro-molecular imaging.

Authors:  Hong Zhang
Journal:  Neurosci Bull       Date:  2014-10       Impact factor: 5.203

Review 3.  Migraine with Brainstem Aura Accompanied by Disorders of Consciousness.

Authors:  Sui-Yi Xu; Hui-Juan Li; Jing Huang; Xiu-Ping Li; Chang-Xin Li
Journal:  J Pain Res       Date:  2021-04-20       Impact factor: 3.133

4.  Complement Component C3 Loss leads to Locomotor Deficits and Altered Cerebellar Internal Granule Cell In Vitro Synaptic Protein Expression in C57BL/6 Mice.

Authors:  Nicholas W DeKorver; Tammy R Chaudoin; Gang Zhao; Dong Wang; Jyothi Arikkath; Stephen J Bonasera
Journal:  Mol Neurobiol       Date:  2021-08-20       Impact factor: 5.590

Review 5.  Migraine With Comorbid Depression: Pathogenesis, Clinical Implications, and Treatment.

Authors:  Nailah Asif; Apurva Patel; Deepanjali Vedantam; Devyani S Poman; Lakshya Motwani
Journal:  Cureus       Date:  2022-06-16

6.  Profiling cerebrovascular function in migraine: A systematic review and meta-analysis.

Authors:  Jemima Sa Dzator; Peter Rc Howe; Rachel Hx Wong
Journal:  J Cereb Blood Flow Metab       Date:  2020-10-22       Impact factor: 6.200

Review 7.  Cortical spreading depression: culprits and mechanisms.

Authors:  Aparna Ann Mathew; Rajitha Panonnummal
Journal:  Exp Brain Res       Date:  2022-01-22       Impact factor: 1.972

Review 8.  Migraine Modulation and Debut after Percutaneous Atrial Septal Defect Closure: A Review.

Authors:  Charles Stevens Leger; Joseph F X DeSouza
Journal:  Front Neurol       Date:  2017-03-20       Impact factor: 4.003

9.  The role of the immune system and the biomarker CD3 + CD4 + CD45RA-CD62L- in the pathophysiology of migraine.

Authors:  Zbyšek Pavelek; Ondřej Souček; Jan Krejsek; Lukáš Sobíšek; Blanka Klímová; Jiří Masopust; Kamil Kuča; Martin Vališ
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

10.  Cervical non-invasive vagus nerve stimulation (nVNS) for preventive and acute treatment of episodic and chronic migraine and migraine-associated sleep disturbance: a prospective observational cohort study.

Authors:  Thomas M Kinfe; Bogdan Pintea; Sajjad Muhammad; Sebastian Zaremba; Sandra Roeske; Bruce J Simon; Hartmut Vatter
Journal:  J Headache Pain       Date:  2015-12-03       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.